1. Home
  2. EMBC vs CII Comparison

EMBC vs CII Comparison

Compare EMBC & CII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • CII
  • Stock Information
  • Founded
  • EMBC 1924
  • CII 2004
  • Country
  • EMBC United States
  • CII United States
  • Employees
  • EMBC N/A
  • CII N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • CII Investment Bankers/Brokers/Service
  • Sector
  • EMBC Health Care
  • CII Finance
  • Exchange
  • EMBC Nasdaq
  • CII Nasdaq
  • Market Cap
  • EMBC 803.0M
  • CII 939.1M
  • IPO Year
  • EMBC N/A
  • CII N/A
  • Fundamental
  • Price
  • EMBC $14.50
  • CII $24.42
  • Analyst Decision
  • EMBC Buy
  • CII
  • Analyst Count
  • EMBC 2
  • CII 0
  • Target Price
  • EMBC $18.50
  • CII N/A
  • AVG Volume (30 Days)
  • EMBC 374.6K
  • CII 78.8K
  • Earning Date
  • EMBC 11-25-2025
  • CII 01-01-0001
  • Dividend Yield
  • EMBC 4.15%
  • CII 6.17%
  • EPS Growth
  • EMBC 18.26
  • CII N/A
  • EPS
  • EMBC 1.42
  • CII N/A
  • Revenue
  • EMBC $1,102,500,000.00
  • CII N/A
  • Revenue This Year
  • EMBC N/A
  • CII N/A
  • Revenue Next Year
  • EMBC N/A
  • CII N/A
  • P/E Ratio
  • EMBC $10.18
  • CII N/A
  • Revenue Growth
  • EMBC N/A
  • CII N/A
  • 52 Week Low
  • EMBC $9.20
  • CII $16.76
  • 52 Week High
  • EMBC $21.48
  • CII $19.81
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 56.37
  • CII 60.54
  • Support Level
  • EMBC $13.61
  • CII $23.36
  • Resistance Level
  • EMBC $14.81
  • CII $24.15
  • Average True Range (ATR)
  • EMBC 0.62
  • CII 0.45
  • MACD
  • EMBC 0.05
  • CII -0.03
  • Stochastic Oscillator
  • EMBC 75.16
  • CII 94.31

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About CII Blackrock Capital and Income Fund Inc.

Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its objective is to provide total return through a combination of current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its total assets in a portfolio of equity securities of U.S. and foreign issuers.

Share on Social Networks: